Algorithm for rapid exclusion of clinically relevant plasma levels of DOACs in patients using the DOAC Dipstick. An expert consensus paper.
Job HarenbergRobert Charles GosselinAdam CukerCecilia BecattiniIngrid PabingerSven PoliJeffrey Ian WeitzWalter AgenoRupert M BauersachsIvana ĆelapPhilip ChoiJames DouketisJonathan DouxfilsIsmail ElalamyJawed FareedAnna FalangaEmmanuel FavalorGrigoris T GerotziafasHarald HerknerSvetlana HetjensRobert KlamrothLars HeubnerFlorian LangerGregory Yoke Hong LipBrain Mac GrorySandra MargetićAnne E MerrelaarMarika PiktaThomas Renne'Michael SchwameisSam SchulmanDaniel StrbianAlfonso TafurFrancesco VioliJulie VassartJeanine WalengaChristel WeissPublished in: Thrombosis and haemostasis (2024)
With the widespread use of direct oral anticoagulants (DOACs), there is an urgent need for a rapid assay to exclude clinically relevant plasma levels. Accurate and rapid determination of DOAC levels would guide medical decision-making to (a) determine the potential contribution of the DOAC to spontaneous or trauma-induced hemorrhage; (b) identify appropriate candidates for reversal, or (c) optimize the timing of urgent surgery or intervention. The DOAC Dipstick test uses a disposable strip to identify factor Xa- or thrombin inhibitors in a urine sample. Based on the results of a systematic literature search followed by an analysis of a simple pooling of five retrieved clinical studies, the test strip has a high sensitivity and an acceptably high negative predictive value when compared with levels measured with liquid chromatography tandem mass spectrometry or calibrated chromogenic assays to reliably exclude plasma DOAC concentrations >30ng/mL. Based on these data, a simple algorithm is proposed to enhance medical decision-making in acute care indications useful primarily in hospitals not having readily available quantitative tests and 24/7. This algorithm not only determines DOAC exposure but also differentiates between factor Xa- and thrombin inhibitors to better guide clinical management.
Keyphrases
- direct oral anticoagulants
- venous thromboembolism
- loop mediated isothermal amplification
- atrial fibrillation
- liquid chromatography tandem mass spectrometry
- machine learning
- healthcare
- acute care
- deep learning
- solid phase extraction
- decision making
- end stage renal disease
- high throughput
- randomized controlled trial
- high resolution
- ejection fraction
- systematic review
- simultaneous determination
- minimally invasive
- newly diagnosed
- chronic kidney disease
- prognostic factors
- electronic health record
- ms ms
- high glucose
- diabetic rats
- neural network
- coronary artery bypass
- sensitive detection
- oxidative stress
- patient reported outcomes
- artificial intelligence
- coronary artery disease
- acute coronary syndrome
- climate change